Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
325.40    -5.20 (-1.57%)
Bid:
325.20
Ask:
325.60
Spread: 0.40 (0.123%)
Market Cap: £1.73b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Response to Press Speculation

3 Aug 2020 07:00

RNS Number : 8453U
Hammerson PLC
03 August 2020
 

3 August 2020

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EC NO. 596/2014) ("MAR")

 

Hammerson plc

 

Response to Press Speculation

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

Hammerson plc (the 'Company') notes recent press speculation.

 

The Company confirms that it is in advanced discussions on the terms of a possible disposal of its 50% interest in VIA Outlets to its joint venture partner APG. It is also considering a possible equity raise by way of a rights issue.

 

The Company continues to take pro-active measures relating to the management of its cost base and cash-flow and in recent weeks it secured approval for the issuance of up to £300m under the Covid Corporate Finance Facility (CCFF) from the Bank of England. Following the reopening of its flagship destinations across Europe, footfall and sales continue to improve and Q3 rent collection in the UK (excluding monthly payments and deferrals) has increased to over 30%.

 

The Company will provide a further update in due course, if appropriate.

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

ENDS

 

This announcement is for information purposes only and shall not constitute or form part of any offer to issue or sell, or the solicitation of any offer to purchase, subscribe for or otherwise acquire, any securities of the Company in the United States (including its territories and possessions, any state of the United States and the District of Columbia) (the "United States" or "US") or any other jurisdiction. No public offering of the Securities is being made in any such jurisdiction. The securities referred to herein (the "Securities") have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States, and accordingly may not be offered, sold, resold, pledged, taken up, exercised, renounced, delivered, distributed or transferred directly or indirectly, into or within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any relevant state or other jurisdiction of the United States. No public offering of the Securities has been or will be made in the United States.

 

For further information:

 

Investor Contact

Josh Warren, Hammerson, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

 

Press Contacts

Hammerson

Catrin Sharp, Head of Corporate Communications

Tel: +44 20 7887 1063

catrin.sharp@hammerson.com

 

FTI Consulting (for Hammerson)

John Waples/ Dido Laurimore

Tel: +44 20 3727 1000/ 0780 1654424

dido.laurimore@fticonsulting.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RSPKKDBNOBKDAFK
Date   Source Headline
23rd Mar 20218:30 amRNSCurrency Conversion & Scrip Reference Share Price
18th Mar 202110:30 amRNSHolding(s) in Company
17th Mar 20211:45 pmRNSDirector/PDMR Shareholding
17th Mar 202110:15 amRNSHolding(s) in Company
16th Mar 20211:15 pmRNSHolding(s) in Company
15th Mar 202111:15 amRNSHolding(s) in Company
12th Mar 20217:01 amRNSDividend Declaration
12th Mar 20217:00 amRNSBoard Changes
12th Mar 20217:00 amRNSFinal Results
11th Mar 20213:30 pmRNSHolding(s) in Company
11th Mar 20219:30 amRNSHolding(s) in Company
10th Mar 202110:15 amRNSHolding(s) in Company
2nd Mar 202110:15 amRNSHolding(s) in Company
1st Mar 202110:15 amRNSHolding(s) in Company
26th Feb 202110:15 amRNSHolding(s) in Company
23rd Feb 20219:30 amRNSHolding(s) in Company
22nd Feb 202111:00 amRNSHolding(s) in Company
19th Feb 202111:00 amRNSHolding(s) in Company
16th Feb 20219:30 amRNSHolding(s) in Company
15th Feb 202111:30 amRNSNotification of 2020 Full Year Results
29th Jan 20213:30 pmRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSOperational and Rent Collection Update
15th Jan 20217:00 amRNSBoard Change
12th Jan 20213:30 pmRNSHolding(s) in Company
8th Jan 202110:30 amRNSHome Member State
8th Jan 20219:30 amRNSHolding(s) in Company
6th Jan 20213:45 pmRNSHolding(s) in Company
24th Dec 20208:30 amRNSNotification of Transactions of Directors /PDMRs
23rd Dec 20208:01 amRNSAdmission to the official list of Euronext Dublin
22nd Dec 20209:30 amRNSHolding(s) in Company
21st Dec 20207:00 amRNSAppointment of new Non-Executive Director
18th Dec 20209:00 amRNSTotal Voting Rights
18th Dec 20207:00 amRNSIntention to seek admission to Euronext Dublin
16th Dec 202012:00 pmRNSInterim 2020 Dividend/Enhanced Script Correction
14th Dec 202010:30 amRNSHolding(s) in Company
8th Dec 20201:15 pmRNSInterim Dividend and Enhanced Scrip Alternative
4th Dec 202012:15 pmRNSResults of the General Meeting
2nd Dec 20209:30 amRNSHolding(s) in Company
30th Nov 20209:30 amRNSBlock listing Interim Review
25th Nov 202010:30 amRNSHolding(s) in Company
19th Nov 20209:00 amRNSCash Fractions for the Enhanced Scrip Dividend
18th Nov 20207:20 amRNSScrip Ratio Announcement
17th Nov 20208:00 amRNSCurrency Conversion & Scrip Reference Share Price
16th Nov 202010:00 amRNSHolding(s) in Company
11th Nov 20207:00 amRNSInterim Dividend and Enhanced Scrip Alternative
4th Nov 20203:30 pmRNSDirector/PDMR Shareholding
3rd Nov 202011:00 amRNSDirector/PDMR Shareholding
2nd Nov 20207:00 amRNSCompletion of VIA Disposal
29th Oct 202011:00 amRNSHolding(s) in Company
21st Oct 20202:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.